These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9868303

  • 21. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB, Zheng JE, Gu JX, Yao JX, Yang J, Liu J, Li XQ, He YL, Yu JM, Wei J, Liu ZP, Huang SA.
    Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
    [Abstract] [Full Text] [Related]

  • 22. HLA-Dr negative acute non-lymphocytic leukemia.
    Lazarchick J, Hopkins M.
    Ann Clin Lab Sci; 1998 Jun; 28(3):150-2. PubMed ID: 9646855
    [Abstract] [Full Text] [Related]

  • 23. Role of blast cell immunophenotyping for the diagnosis and prognosis of acute myeloid leukemia.
    Dubosc-Marchenay N, Lacombe F, Dumain P, Marit G, Montastruc M, Belloc F, Reiffers J.
    Hematol Oncol; 1992 Jun; 10(5):235-49. PubMed ID: 1493908
    [Abstract] [Full Text] [Related]

  • 24. [Immunophenotyping of eighty six children with acute lymphoblastic leukemia by three-color flow cytometry].
    Wan S, Gong W, Sun X, Xu J, Tian D.
    Zhonghua Xue Ye Xue Za Zhi; 2002 Feb; 23(2):83-6. PubMed ID: 12015077
    [Abstract] [Full Text] [Related]

  • 25. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination.
    Thalhammer-Scherrer R, Mitterbauer G, Simonitsch I, Jaeger U, Lechner K, Schneider B, Fonatsch C, Schwarzinger I.
    Am J Clin Pathol; 2002 Mar; 117(3):380-9. PubMed ID: 11888077
    [Abstract] [Full Text] [Related]

  • 26. Anti-CD10 immunoperoxidase staining of paraffin-embedded acute leukemias: comparison with flow cytometric immunophenotyping.
    Bavikatty NR, Ross CW, Finn WG, Schnitzer B, Singleton TP.
    Hum Pathol; 2000 Sep; 31(9):1051-4. PubMed ID: 11014570
    [Abstract] [Full Text] [Related]

  • 27. Immunophenotyping of acute leukaemias.
    Béné MC.
    Immunol Lett; 2005 Apr 15; 98(1):9-21. PubMed ID: 15790504
    [Abstract] [Full Text] [Related]

  • 28. Immunophenotyping in the classification of acute leukemia in adults. Interpretation of multiple lineage reactivity.
    Kaplan SS, Penchansky L, Stolc V, Contis L, Krause JR.
    Cancer; 1989 Apr 15; 63(8):1520-7. PubMed ID: 2538217
    [Abstract] [Full Text] [Related]

  • 29. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
    Lewis RE, Cruse JM, Webb RN, Sanders CM, Beason K.
    Exp Mol Pathol; 2007 Oct 15; 83(2):269-73. PubMed ID: 17603036
    [Abstract] [Full Text] [Related]

  • 30. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
    Pálóczi K, Nahajevszky S, Jakab K, Regéczy N, Gopcsa L, László E, Földi J.
    Orv Hetil; 2000 Nov 12; 141(46):2487-92. PubMed ID: 11126681
    [Abstract] [Full Text] [Related]

  • 31. Diagnosis and classification of the acute leukemias: recent advances and controversial issues.
    Taylor CG, Stasi R, Bastianelli C, Venditti A, Del Poeta G, Amadori S, Sargent J.
    Hematopathol Mol Hematol; 1996 Nov 12; 10(1-2):1-38. PubMed ID: 8792146
    [Abstract] [Full Text] [Related]

  • 32. Enzymes transducing extracellular signals in acute myeloid human leukemias.
    Losa GA, Leoni L, Grob JP.
    Schweiz Med Wochenschr; 1993 Jan 23; 123(3):69-73. PubMed ID: 8093982
    [Abstract] [Full Text] [Related]

  • 33. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M, Hecht K, Reif S, Pelka-Fleischer R, Pfister K, Schmetzer H.
    Eur J Haematol; 2004 Feb 23; 72(2):89-106. PubMed ID: 14962246
    [Abstract] [Full Text] [Related]

  • 34. Myeloperoxidase gene expression in acute leukemias.
    Morishita Y, Yano K.
    Nihon Ketsueki Gakkai Zasshi; 1989 Dec 23; 52(8):1459-62. PubMed ID: 2560887
    [Abstract] [Full Text] [Related]

  • 35. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA, Fuller SG, Borowitz MJ.
    Cytometry B Clin Cytom; 2009 Mar 23; 76(2):150-5. PubMed ID: 18831072
    [Abstract] [Full Text] [Related]

  • 36. New methodologic approaches for immunophenotyping acute leukemias.
    Basso G, Buldini B, De Zen L, Orfao A.
    Haematologica; 2001 Jul 23; 86(7):675-92. PubMed ID: 11454522
    [Abstract] [Full Text] [Related]

  • 37. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
    Zheng J, Wang X, Hu Y, Yang J, Liu J, He Y, Gong Q, Yao J, Li X, Du W, Huang S.
    Cytometry B Clin Cytom; 2008 Jan 23; 74(1):25-9. PubMed ID: 18061959
    [Abstract] [Full Text] [Related]

  • 38. Normal lymphocytes from leukemic samples as an internal quality control for fluorescence intensity in immunophenotyping of acute leukemias.
    Ratei R, Karawajew L, Lacombe F, Jagoda K, Del Poeta G, Kraan J, De Santiago M, Kappelmayer J, Björklund E, Ludwig WD, Gratama J, Orfao A, European Working Group of Clinical Cell Analysis (EWGCCA).
    Cytometry B Clin Cytom; 2006 Jan 23; 70(1):1-9. PubMed ID: 16278833
    [Abstract] [Full Text] [Related]

  • 39. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Graf M, Reif S, Hecht K, Pelka-Fleischer R, Pfister K, Schmetzer H.
    Am J Hematol; 2005 May 23; 79(1):26-35. PubMed ID: 15849776
    [Abstract] [Full Text] [Related]

  • 40. Development of quartz-crystal-microbalance-based immunosensor array for clinical immunophenotyping of acute leukemias.
    Zeng H, Wang H, Chen F, Xin H, Wang G, Xiao L, Song K, Wu D, He Q, Shen G.
    Anal Biochem; 2006 Apr 01; 351(1):69-76. PubMed ID: 16455039
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.